Disc Medicine, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRON research report →
Range $86 – $128
Price Chart
About the company
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases.
- CEO
- John D. Quisel
- IPO
- 2020
- Employees
- 165
- HQ
- Watertown, MA, US
Get TickerSpark's AI analysis on IRON
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.43B
- P/E
- -9.60
- Fwd P/E
- 26.86
- PEG
- 0.26
- P/S
- 0.00
- P/B
- 3.80
- EV/EBITDA
- -9.90
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -37.17%
- ROIC
- -38.19%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-236,022,000
- Net Income
- $-212,184,000-94.0%
- EPS
- $-6.01-51.8%
- OCF Growth
- -92.1%
- FCF Growth
- -92.0%
- 52W High
- $99.50
- 52W Low
- $40.00
- 50D MA
- $74.88
- 200D MA
- $71.81
- Beta
- 2.05
- RSI (14)
- 28
- Avg Volume
- 459.61K
No earnings-call transcripts are available for IRON yet.
- Free Float
- 71.9%
- Shares Outstanding
- 38.39M
- Float Shares
- 27.61M
of shares held by institutions
209 13F filers
Buy/sell ratio 0.31. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Fmr LLC | 4.89M | ▼ 692.42K |
| Blackrock, Inc. | 2.47M | ▲ 194.07K |
| Ra Capital Management, L.P. | 2.45M | 0 |
| Jpmorgan Chase & Co | 1.88M | ▲ 504.31K |
| Price T Rowe Associates Inc | 1.88M | ▲ 326.05K |
| Vanguard Group Inc | 1.77M | ▲ 319.62K |
| Wellington Management Group Llp | 1.74M | ▲ 5.97K |
| State Street Corp | 1.65M | ▼ 49.41K |
| Vestal Point Capital, LP | 1.55M | ▲ 850.00K |
| Atlas Venture Life Science Advisors, LLC | 1.51M | 0 |
| Vanguard Capital Management LLC | 1.37M | ▼ 6.40K |
| Frazier Life Sciences Management, L.P. | 1.35M | 0 |
Held by 266 ETFs
Biggest fund positions in IRON by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 15, 26 | Quisel John D | other | 36,000 |
| Sep 15, 26 | Quisel John D | other | 36,000 |
| Sep 11, 26 | Bitterman Kevin | other | 10,000 |
| Sep 11, 26 | Bitterman Kevin | other | 10,000 |
| Sep 11, 26 | Bitterman Kevin | other | 7,136 |
| Sep 11, 26 | Bitterman Kevin | other | 10,000 |
| Sep 11, 26 | Bitterman Kevin | sell | 27,136 |
| Sep 11, 26 | Bitterman Kevin | other | 7,136 |
| Sep 11, 26 | Bitterman Kevin | other | 10,000 |
| Sep 4, 26 | Bitterman Kevin | sell | 912 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IRON coverage
Recent articles, reports, and earnings notes.
No research on IRON yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IRON report →Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com · Oct 5
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com · Oct 4
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com · Oct 3
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
prnewswire.com · Oct 2
ROSEN, A LEADING NATIONAL FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com · Sep 30
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com · Sep 29
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com · Sep 28
ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com · Sep 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.